Paul Greaves
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 5%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Lymphoma Diagnosis and Treatment 13
- Autoimmune Bullous Skin Diseases 3
- Genetics 11
- Hemoglobinopathies and Related Disorders 5
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- John G. Gribben (16 shared papers)Janet M. Matthews (7 shared papers)Andrew Owen (5 shared papers)Andrew James Clear (7 shared papers)Maria Calaminici (6 shared papers)Andrew Wilson (5 shared papers)Rita Coutinho (5 shared papers)Roger J. Amos (2 shared papers)
- Journals
- British Journal of Haematology (9 papers)Blood (9 papers)The Lancet (6 papers)Clinical Medicine (3 papers)Haematologica (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Paul Greaves
36 papers receiving 2.8k citations
Paul Greaves's Hit Papers
Peers
Comparison fields: 5 of 121
- Infectious Diseases 1.2k
- Oncology 810
- Neurology 421
- Applied Microbiology and Biotechnology 50
- Pathology and Forensic Medicine 345
Countries citing papers authored by Paul Greaves
This map shows the geographic impact of Paul Greaves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Greaves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Greaves more than expected).
Fields of papers citing papers by Paul Greaves
This network shows the impact of papers produced by Paul Greaves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Greaves. The network helps show where Paul Greaves may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Greaves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 443 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 6 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 7 | 2012 | 166 | |
| 8 | 2013 | 138 | |
| 9 | 2012 | 127 | |
| 10 | 2014 | 97 | |
| 11 | 2023 | 83 | |
| 12 | 2013 | 64 | |
| 13 | 2014 | 54 | |
| 14 | 2013 | 46 | |
| 15 | 2013 | 35 | |
| 16 | 2022 | 16 | |
| 17 | 2016 | 14 | |
| 18 | 2023 | 14 | |
| 19 | 2015 | 12 | |
| 20 | 2012 | 11 |
About Paul Greaves
Paul Greaves is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Infectious Diseases, having authored 38 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Hemoglobinopathies and Related Disorders (5 papers), Viral-associated cancers and disorders (4 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), CAR-T cell therapy research (3 papers), Autoimmune Bullous Skin Diseases (3 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Oncology (810 citations), Neurology (421 citations), Applied Microbiology and Biotechnology (50 citations) and Pathology and Forensic Medicine (345 citations). Paul Greaves has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John G. Gribben, Janet M. Matthews, Andrew Owen, Andrew James Clear, Maria Calaminici, Andrew Wilson, Rita Coutinho, Roger J. Amos, Dimitris A. Tsitsikas and Giorgio Gallinella. Their work appears in journals such as British Journal of Haematology, Blood, The Lancet, Clinical Medicine and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.